Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb - 53 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of May 14, 2025 is 44.12.
  • The all-time high Bristol Myers Squibb stock closing price was 72.96 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 63.33, which is 43.5% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 39.35, which is 10.8% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 51.78.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 55.1880 55.5677 62.4333 44.1200 44.1200 -20.28%
2024 47.6684 49.1398 58.6499 38.1833 55.3426 15.81%
2023 57.5896 64.9856 67.5573 45.1534 47.7893 -26.14%
2022 64.7896 53.9742 72.9626 53.9742 64.7068 18.98%
2021 54.3034 52.3079 59.9663 46.7782 54.3841 2.88%
2020 50.7007 52.3159 55.6940 38.3242 52.8618 0.41%
2019 40.6504 41.5710 52.6462 34.7861 52.6462 27.74%
2018 45.3367 47.3391 53.6108 38.6611 41.2142 -12.90%
2017 44.0223 44.6887 50.4585 35.4271 47.3159 7.71%
2016 47.0497 49.4811 57.3110 37.0063 43.9295 -13.49%
2015 46.9633 42.9272 51.9132 41.8039 50.7803 19.26%
2014 37.0414 36.6754 43.9448 32.9185 42.5809 14.18%
2013 30.2389 22.2623 37.5224 22.2623 37.2928 69.96%
2012 22.0844 22.6614 24.0955 20.7439 21.9424 -3.80%
2011 18.4419 16.4208 22.8427 15.6207 22.8103 39.44%
2010 15.5702 15.2713 17.0571 13.5309 16.3590 8.74%
2009 12.5273 13.4574 15.2764 9.8676 15.0448 14.82%
2008 11.7664 13.9004 14.4058 9.5953 13.1024 -6.03%
2007 14.9364 13.4784 16.7351 13.3353 13.9429 4.79%
2006 11.9897 11.2223 13.3050 10.1161 13.3050 19.90%
2005 11.4954 11.7352 12.4969 10.1551 11.0968 -6.14%
2004 11.4037 13.0800 13.6549 10.2612 11.8228 -7.24%
2003 10.9637 10.2452 12.7458 9.0088 12.7458 29.14%
2002 12.7910 20.7903 20.9742 8.5568 9.8700 -52.40%
2001 22.4510 27.1572 27.1572 19.9239 20.7371 -26.16%
2000 21.9612 24.0762 28.0830 16.3203 28.0830 17.10%
1999 25.3342 24.0371 29.1203 21.3228 23.9828 -2.79%
1998 19.9226 17.2489 24.6708 16.3717 24.6708 43.03%
1997 13.7422 9.5641 17.7514 9.5641 17.2489 77.25%
1996 7.8819 7.0875 10.2596 6.7230 9.7314 36.90%
1995 5.6156 4.6691 7.1288 4.6491 7.1082 53.55%
1994 4.3241 4.3491 4.7852 3.8867 4.6291 6.47%
1993 4.2790 4.7638 4.7638 3.7666 4.3479 -9.22%
1992 5.0129 6.0666 6.1010 4.3621 4.7893 -21.05%
1991 5.3477 4.4339 6.0666 4.0845 6.0666 36.06%
1990 3.8418 3.6508 4.4664 3.2665 4.4589 24.31%
1989 3.1030 2.7280 3.6229 2.7049 3.5868 28.94%
1988 2.5537 2.5522 2.7970 2.2946 2.7818 14.36%
1987 2.7589 2.4154 3.1490 2.1330 2.4324 2.84%
1986 2.1038 1.7282 2.4723 1.5869 2.3653 35.83%
1985 1.5115 1.3049 1.7647 1.2667 1.7414 30.58%
1984 1.1576 1.0620 1.3336 1.0281 1.3336 28.17%
1983 0.9395 0.8004 1.1645 0.7526 1.0405 30.54%
1982 0.6958 0.6085 0.8682 0.5897 0.7971 31.21%
1981 0.5889 0.5634 0.6603 0.5095 0.6075 9.16%
1980 0.4439 0.3893 0.5675 0.3291 0.5565 40.53%
1979 0.3605 0.3658 0.4014 0.3278 0.3960 7.87%
1978 0.3384 0.3305 0.3977 0.2797 0.3671 10.24%
1977 0.3161 0.3256 0.3499 0.2790 0.3330 1.34%
1976 0.3448 0.3236 0.3913 0.2944 0.3286 2.08%
1975 0.2859 0.2329 0.3419 0.2147 0.3219 41.00%
1974 0.2071 0.2059 0.2491 0.1429 0.2283 11.80%
1973 0.2649 0.2935 0.3059 0.1924 0.2042 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $94.814B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $210.016B 15.68
Amgen (AMGN) United States $145.423B 13.03
Gilead Sciences (GILD) United States $126.172B 13.10
Vertex Pharmaceuticals (VRTX) United States $110.936B 0.00
GSK (GSK) United Kingdom $74.998B 8.91
CSL (CSLLY) Australia $73.804B 0.00
Regeneron Pharmaceuticals (REGN) United States $61.989B 15.05
Alnylam Pharmaceuticals (ALNY) United States $34.795B 0.00
Argenex SE (ARGX) Netherlands $33.123B 90.41
BioNTech SE (BNTX) Germany $22.717B 0.00
BeiGene (ONC) Cayman Islands $22.259B 0.00
Royalty Pharma (RPRX) United States $18.919B 7.80
Biogen (BIIB) United States $18.046B 7.79
Illumina (ILMN) United States $12.711B 24.11
Genmab (GNMSF) Denmark $12.475B 12.76
Genmab (GMAB) Denmark $12.382B 13.89
Insmed (INSM) United States $11.968B 0.00
Incyte (INCY) United States $11.771B 89.43
BioMarin Pharmaceutical (BMRN) United States $11.464B 18.62
Swedish Orphan Biovitrum (BIOVF) Sweden $10.858B 27.73
Exelixis (EXEL) United States $10.183B 17.11
Exact Sciences (EXAS) United States $10.124B 0.00
Moderna (MRNA) United States $9.858B 0.00
Ascendis Pharma (ASND) Denmark $9.848B 0.00
QIAGEN (QGEN) Netherlands $9.361B 18.21
Bio-Techne Corp (TECH) United States $8.091B 30.18
Roivant Sciences (ROIV) United Kingdom $7.678B 0.00
Revolution Medicines (RVMD) United States $7.441B 0.00
Repligen (RGEN) United States $7.391B 82.74
Bio-Rad Laboratories (BIO.B) United States $7.005B 23.68
Blueprint Medicines (BPMC) United States $6.420B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.343B 6.11
Halozyme Therapeutics (HALO) United States $6.189B 11.85
Verona Pharma American Depositary Share (VRNA) United Kingdom $5.742B 0.00
Legend Biotech (LEGN) United States $5.708B 0.00
Telix Pharmaceuticals (TLX) Australia $5.646B 0.00
TG Therapeutics (TGTX) United States $5.298B 139.04
Axsome Therapeutics (AXSM) United States $5.203B 0.00
Guardant Health (GH) United States $5.124B 0.00
Nuvalent (NUVL) United States $5.114B 0.00
Alkermes (ALKS) Ireland $5.086B 13.65
ADMA Biologics Inc (ADMA) United States $4.724B 35.50
Zealand Pharma (ZLDPF) Denmark $4.527B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $4.063B 0.00
Krystal Biotech (KRYS) United States $3.888B 29.96
Vaxcyte (PCVX) United States $3.877B 0.00
PTC Therapeutics (PTCT) United States $3.677B 6.40
Cytokinetics (CYTK) United States $3.656B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.613B 0.00
Avidity Biosciences (RNA) United States $3.601B 0.00
Sarepta Therapeutics (SRPT) United States $3.558B 0.00
SpringWorks Therapeutics (SWTX) United States $3.481B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.347B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.214B 0.00
Arcellx (ACLX) United States $3.210B 0.00
Akero Therapeutics (AKRO) United States $3.190B 0.00
Alvotech (ALVO) Luxembourg $3.184B 18.21
Zai Lab (ZLAB) China $3.158B 0.00
Viking Therapeutics (VKTX) United States $3.115B 0.00
Scholar Rock Holding (SRRK) United States $2.979B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.879B 25.29
Merus (MRUS) Netherlands $2.832B 0.00
Protagonist Therapeutics (PTGX) United States $2.744B 59.03
Metsera (MTSR) United States $2.742B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.467B 0.00
Immunovant (IMVT) United States $2.381B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.291B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.271B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.242B 0.00
ImmunityBio (IBRX) United States $2.215B 0.00
Vericel (VCEL) United States $2.197B 1454.67
Apellis Pharmaceuticals (APLS) United States $2.172B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.110B 0.00
Ascentage Pharma Group - (AAPG) China $2.093B 0.00
Denali Therapeutics (DNLI) United States $2.072B 0.00
Ligand Pharmaceuticals (LGND) United States $2.038B 0.00
Kymera Therapeutics (KYMR) United States $2.028B 0.00
NovoCure (NVCR) Jersey $2.022B 0.00
Biohaven (BHVN) United States $1.992B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.974B 13.12
Certara (CERT) United States $1.970B 36.79
Belite Bio (BLTE) United States $1.939B 0.00
Twist Bioscience (TWST) United States $1.935B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.868B 0.00
Bavarian Nordic (BVNRY) Denmark $1.866B 9.86
Travere Therapeutics (TVTX) United States $1.860B 0.00
Amicus Therapeutics (FOLD) United States $1.854B 200.67
CG Oncology (CGON) United States $1.843B 0.00
Apogee Therapeutics (APGE) United States $1.830B 0.00
Beam Therapeutics (BEAM) United States $1.815B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.742B 0.00
Agios Pharmaceuticals (AGIO) United States $1.664B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.647B 0.00
Disc Medicine (IRON) United States $1.602B 0.00
Edgewise Therapeutics (EWTX) United States $1.566B 0.00
IDEAYA Biosciences (IDYA) United States $1.528B 0.00
Mesoblast (MESO) Australia $1.522B 0.00
GRAIL (GRAL) United States $1.514B 0.00
Janux Therapeutics (JANX) United States $1.499B 0.00
MannKind (MNKD) United States $1.435B 29.50
Immunocore Holdings (IMCR) United Kingdom $1.429B 0.00
Adaptive Biotechnologies (ADPT) United States $1.411B 0.00
Vera Therapeutics (VERA) United States $1.376B 0.00
Structure Therapeutics (GPCR) United States $1.370B 0.00
Liquidia Technologies (LQDA) United States $1.367B 0.00
ANI Pharmaceuticals (ANIP) United States $1.350B 13.84
Celldex Therapeutics (CLDX) United States $1.302B 0.00
Dynavax Technologies (DVAX) United States $1.155B 68.71
89BIO (ETNB) United States $1.139B 0.00
BGM Group (BGM) China $1.125B 0.00
Pacira BioSciences (PCRX) United States $1.083B 10.31
Gyre Therapeutics (GYRE) United States $1.078B 287.50
NeoGenomics (NEO) United States $1.076B 0.00
MiMedx (MDXG) United States $1.059B 25.61
Viridian Therapeutics (VRDN) United States $1.045B 0.00
Anbio Biotechnology (NNNN) Germany $1.020B 0.00
Novavax (NVAX) United States $1.003B 2.34
Mineralys Therapeutics (MLYS) United States $0.990B 0.00
WAVE Life Sciences (WVE) Singapore $0.985B 0.00
Arcus Biosciences (RCUS) United States $0.918B 0.00
Spyre Therapeutics (SYRE) United States $0.889B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.877B 0.00
Intellia Therapeutics (NTLA) United States $0.862B 0.00
Pharvaris (PHVS) Netherlands $0.842B 0.00
LENZ Therapeutics (LENZ) United States $0.815B 0.00
Zymeworks (ZYME) United States $0.808B 0.00
CorMedix Inc (CRMD) United States $0.789B 52.86
Oculis Holding AG (OCS) Switzerland $0.775B 0.00
Niagen Bioscience (NAGE) United States $0.766B 108.11
Geron (GERN) United States $0.764B 0.00
CureVac (CVAC) Germany $0.762B 4.14
Praxis Precision Medicines (PRAX) United States $0.760B 0.00
Nurix Therapeutics (NRIX) United States $0.742B 0.00
Nuvation Bio (NUVB) United States $0.742B 0.00
Bicara Therapeutics (BCAX) United States $0.711B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.706B 0.00
UniQure (QURE) Netherlands $0.702B 0.00
Anavex Life Sciences (AVXL) United States $0.693B 0.00
Immunome (IMNM) United States $0.688B 0.00
Pharming Group (PHAR) Netherlands $0.680B 0.00
ArriVent BioPharma (AVBP) United States $0.653B 0.00
Vir Biotechnology (VIR) United States $0.650B 0.00
Trevi Therapeutics (TRVI) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.642B 0.00
AbCellera Biologics (ABCL) Canada $0.627B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Pharming Group (PHGUF) Netherlands $0.613B 0.00
Arbutus Biopharma (ABUS) United States $0.611B 0.00
Dianthus Therapeutics (DNTH) United States $0.606B 0.00
AnaptysBio (ANAB) United States $0.603B 0.00
Iovance Biotherapeutics (IOVA) United States $0.598B 0.00
Replimune (REPL) United States $0.571B 0.00
Cogent Biosciences (COGT) United States $0.568B 0.00
Sionna Therapeutics (SION) United States $0.566B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.562B 0.00
Keros Therapeutics (KROS) United States $0.547B 0.00
Tyra Biosciences (TYRA) United States $0.530B 0.00
Immatics (IMTX) Germany $0.528B 0.00
Opthea (OPT) Australia $0.525B 0.00
GH Research (GHRS) Ireland $0.523B 0.00
Kura Oncology (KURA) United States $0.502B 0.00
Castle Biosciences (CSTL) United States $0.492B 33.39
Stoke Therapeutics (STOK) United States $0.488B 11.30
Mind Medicine (MindMed) (MNMD) United States $0.480B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.471B 0.00
Urogen Pharma (URGN) United States $0.468B 0.00
Upstream Bio (UPB) United States $0.465B 0.00
Arvinas (ARVN) United States $0.459B 0.00
Eton Pharmaceuticals (ETON) United States $0.458B 0.00
Fortrea Holdings (FTRE) United States $0.453B 12.50
Cullinan Therapeutics (CGEM) United States $0.450B 0.00
Maze Therapeutics (MAZE) United States $0.432B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
Sage Therapeutics (SAGE) United States $0.414B 0.00
Northwest Biotherapeutics (NWBO) United States $0.414B 0.00
MeiraGTx Holdings (MGTX) United States $0.412B 0.00
REGENXBIO (RGNX) United States $0.410B 0.00
Celcuity (CELC) United States $0.409B 0.00
Prothena (PRTA) Ireland $0.409B 0.00
PureTech Health (PRTC) United States $0.408B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.407B 0.00
Sana Biotechnology (SANA) United States $0.405B 0.00
Precigen (PGEN) United States $0.398B 0.00
Kamada (KMDA) Israel $0.396B 26.50
Verastem (VSTM) United States $0.384B 0.00
Abivax SA (ABVX) France $0.383B 0.00
Zenas BioPharma (ZBIO) United States $0.380B 0.00
Myriad Genetics (MYGN) United States $0.379B 0.00
Absci (ABSI) United States $0.378B 0.00
Oric Pharmaceuticals (ORIC) United States $0.377B 0.00
Cytek Biosciences (CTKB) United States $0.377B 0.00
Tectonic Therapeutic (TECX) United States $0.377B 0.00
Erasca (ERAS) United States $0.377B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.369B 0.00
Rapport Therapeutics (RAPP) United States $0.365B 0.00
Alpha Teknova (TKNO) United States $0.360B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.350B 0.00
Checkpoint Therapeutics (CKPT) United States $0.348B 0.00
MBX Biosciences (MBX) United States $0.343B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.338B 0.00
Entrada Therapeutics (TRDA) United States $0.330B 10.74
XOMA Royalty (XOMA) United States $0.329B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.322B 0.00
Olema Pharmaceuticals (OLMA) United States $0.320B 0.00
Emergent Biosolutions (EBS) United States $0.319B 0.00
Fulcrum Therapeutics (FULC) United States $0.313B 0.00
Benitec Biopharma (BNTC) United States $0.309B 0.00
DBV Technologies S.A (DBVT) France $0.301B 0.00
ITeos Therapeutics (ITOS) United States $0.300B 0.00
Septerna (SEPN) United States $0.300B 0.00
ATyr Pharma (ATYR) United States $0.295B 0.00
Compass Therapeutics (CMPX) United States $0.277B 0.00
Prima BioMed (IMMP) Australia $0.276B 0.00
Abeona Therapeutics (ABEO) United States $0.275B 0.00
Humacyte (HUMA) United States $0.268B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Candel Therapeutics (CADL) United States $0.266B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.265B 0.00
Cartesian Therapeutics (RNAC) United States $0.265B 0.00
Aura Biosciences (AURA) United States $0.264B 0.00
Lifecore Biomedical (LFCR) United States $0.257B 0.00
Palvella Therapeutics (PVLA) United States $0.255B 0.00
Terns Pharmaceuticals (TERN) United States $0.253B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.249B 50.50
Gossamer Bio (GOSS) United States $0.248B 0.00
Allogene Therapeutics (ALLO) United States $0.247B 0.00
Cidara Therapeutics (CDTX) United States $0.243B 0.00
Foghorn Therapeutics (FHTX) United States $0.241B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.235B 0.00
MaxCyte (MXCT) United States $0.234B 0.00
Third Harmonic Bio (THRD) United States $0.232B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.231B 0.00
Bright Minds Biosciences (DRUG) United States $0.230B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.228B 0.00
Atea Pharmaceuticals (AVIR) United States $0.225B 0.00
Rezolute (RZLT) United States $0.222B 0.00
Neurogene (NGNE) United States $0.221B 0.00
Astria Therapeutics (ATXS) United States $0.220B 0.00
Aardvark Therapeutics (AARD) United States $0.220B 0.00
Solid Biosciences (SLDB) United States $0.216B 0.00
Adocia (ADOCY) France $0.213B 0.00
Semper Paratus Acquisition (TVGN) United States $0.213B 0.00
Amarin (AMRN) Ireland $0.213B 0.00
Kodiak Sciences (KOD) United States $0.213B 0.00
Codexis (CDXS) United States $0.212B 0.00
BioStem Technologies (BSEM) $0.211B 8.59
ACELYRIN, INC (SLRN) United States $0.211B 0.00
Alumis (ALMS) United States $0.211B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Monopar Therapeutics (MNPR) United States $0.207B 0.00
Ocugen (OCGN) United States $0.205B 0.00
Design Therapeutics (DSGN) United States $0.203B 0.00
CytomX Therapeutics (CTMX) United States $0.202B 5.21
Annexon (ANNX) United States $0.192B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.189B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.188B 0.00
Actuate Therapeutics (ACTU) United States $0.188B 0.00
Inventiva S.A (IVA) France $0.188B 0.00
INmune Bio (INMB) United States $0.185B 0.00
CARGO Therapeutics (CRGX) United States $0.183B 0.00
Voyager Therapeutics (VYGR) United States $0.182B 0.00
Cardiff Oncology (CRDF) United States $0.181B 0.00
TuHURA Biosciences (HURA) United States $0.179B 0.00
Adherex Technologies (FENC) United States $0.179B 0.00
Anika Therapeutics (ANIK) United States $0.178B 0.00
Nuvectis Pharma (NVCT) United States $0.176B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.174B 0.00
Innate Pharma S.A (IPHA) France $0.171B 0.00
DiaMedica Therapeutics (DMAC) United States $0.171B 0.00
Prime Medicine (PRME) United States $0.167B 0.00
Inhibrx Biosciences (INBX) United States $0.163B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.161B 0.00
Molecular Partners AG (MOLN) Switzerland $0.161B 0.00
AC Immune (ACIU) Switzerland $0.158B 0.00
Tango Therapeutics (TNGX) United States $0.152B 0.00
Puma Biotechnology (PBYI) United States $0.149B 3.91
EnGene Holdings (ENGN) Canada $0.147B 0.00
BioAge Labs (BIOA) United States $0.143B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.139B 0.00
Nkarta (NKTX) United States $0.138B 0.00
Galena Biopharma (SLS) United States $0.133B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.131B 0.00
Greenwich LifeSciences (GLSI) United States $0.129B 0.00
Editas Medicine (EDIT) United States $0.126B 0.00
EXoZymes (EXOZ) United States $0.122B 0.00
Compugen (CGEN) Israel $0.120B 0.00
Theratechnologies (THTX) Canada $0.120B 0.00
InflaRx (IFRX) Germany $0.120B 0.00
Vigil Neuroscience (VIGL) United States $0.118B 0.00
Nautilus Biotechnology (NAUT) United States $0.117B 0.00
ScPharmaceuticals (SCPH) United States $0.117B 0.00
Seer (SEER) United States $0.115B 0.00
Fate Therapeutics (FATE) United States $0.115B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.113B 0.00
Alector (ALEC) United States $0.111B 0.00
Alpha Cognition (ACOG) Canada $0.111B 0.00
Neumora Therapeutics (NMRA) United States $0.110B 0.00
Black Diamond Therapeutics (BDTX) United States $0.110B 0.00
BioHarvest Sciences (BHST) Canada $0.107B 0.00
Sangamo Therapeutics (SGMO) United States $0.107B 0.00
C4 Therapeutics (CCCC) United States $0.107B 0.00
Invivyd (IVVD) United States $0.103B 0.00
Kyverna Therapeutics (KYTX) United States $0.100B 0.00
Rapt Therapeutics (RAPT) United States $0.099B 0.00
Contineum Therapeutics (CTNM) United States $0.099B 0.00
Sagimet Biosciences (SGMT) United States $0.098B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
HilleVax (HLVX) United States $0.096B 0.00
Coherus BioSciences (CHRS) United States $0.096B 0.00
Immunic (IMUX) United States $0.095B 0.00
Genelux (GNLX) United States $0.094B 0.00
Agenus (AGEN) United States $0.093B 0.00
Elicio Therapeutics (ELTX) United States $0.091B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.091B 0.00
Entera Bio (ENTX) Israel $0.091B 0.00
XBiotech (XBIT) United States $0.091B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.087B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.086B 0.00
Climb Bio (CLYM) United States $0.086B 0.00
Ventyx Biosciences (VTYX) United States $0.085B 0.00
Pliant Therapeutics (PLRX) United States $0.085B 0.00
Instil Bio (TIL) United States $0.084B 0.00
Zura Bio (ZURA) United States $0.083B 0.00
Genenta Science S.p.A (GNTA) Italy $0.081B 0.00
Adagene (ADAG) China $0.081B 0.00
Senti Biosciences (SNTI) United States $0.081B 0.00
Cellectis S.A (CLLS) France $0.078B 0.00
Elutia (ELUT) United States $0.077B 0.00
CervoMed (CRVO) United States $0.076B 0.00
TScan Therapeutics (TCRX) United States $0.075B 0.00
I-Mab (IMAB) United States $0.075B 0.00
Medicus Pharma (MDCX) United States $0.074B 0.00
Caribou Biosciences (CRBU) United States $0.073B 0.00
Jasper Therapeutics (JSPR) United States $0.072B 0.00
Exicure (XCUR) United States $0.072B 0.00
MediciNova (MNOV) United States $0.072B 0.00
Inovio Pharmaceuticals (INO) United States $0.070B 0.00
Inozyme Pharma (INZY) United States $0.070B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
Sutro Biopharma (STRO) United States $0.069B 0.00
IGM Biosciences (IGMS) United States $0.069B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
Adlai Nortye (ANL) Cayman Islands $0.068B 0.00
Cabaletta Bio (CABA) United States $0.067B 0.00
VTv Therapeutics (VTVT) United States $0.066B 0.00
IO Biotech (IOBT) Denmark $0.066B 0.00
Citius Oncology (CTOR) United States $0.066B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.065B 0.00
Oncobiologics (OTLK) United States $0.065B 0.00
Seres Therapeutics (MCRB) United States $0.064B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.064B 0.00
Alto Neuroscience (ANRO) United States $0.064B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.064B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.064B 0.00
Applied Therapeutics (APLT) United States $0.062B 0.00
Repare Therapeutics (RPTX) Canada $0.061B 0.00
Biomea Fusion (BMEA) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Skye Bioscience (SKYE) United States $0.060B 0.00
Xilio Therapeutics (XLO) United States $0.060B 0.00
PDS Biotechnology (PDSB) United States $0.058B 0.00
Cue Biopharma (CUE) United States $0.058B 0.00
Ikena Oncology (IKNA) United States $0.056B 0.00
Adicet Bio (ACET) United States $0.055B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
Renovaro (RENB) United States $0.053B 0.00
Fortress Biotech (FBIO) United States $0.051B 0.00
Akoya Biosciences (AKYA) United States $0.051B 0.00
PepGen (PEPG) United States $0.050B 0.00
Artiva Biotherapeutics (ARTV) United States $0.050B 0.00
OKYO Pharma (OKYO) $0.048B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.047B 0.00
Adverum Biotechnologies (ADVM) United States $0.046B 0.00
Oncolytics Biotech (ONCY) Canada $0.046B 0.00
Immuneering (IMRX) United States $0.046B 0.00
Shattuck Labs (STTK) United States $0.046B 0.00
Werewolf Therapeutics (HOWL) United States $0.046B 0.00
Forte Biosciences (FBRX) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.045B 0.00
Celularity (CELU) United States $0.045B 0.00
Lantern Pharma (LTRN) United States $0.044B 0.00
Kronos Bio (KRON) United States $0.044B 0.00
Opus Genetics (IRD) United States $0.044B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Connect Biopharma Holdings (CNTB) United States $0.042B 0.00
Quince Therapeutics (QNCX) United States $0.042B 0.00
Pluri (PLUR) Israel $0.042B 0.00
Whitehawk Therapeutics (WHWK) United States $0.041B 0.00
CAMP4 Therapeutics (CAMP) United States $0.041B 0.00
Tvardi Therapeutics (TVRD) United States $0.040B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.040B 0.00
Atara Biotherapeutics (ATRA) United States $0.040B 0.00
TELA Bio (TELA) United States $0.039B 0.00
Spero Therapeutics (SPRO) United States $0.039B 0.00
RenovoRx (RNXT) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.037B 0.00
Alterity Therapeutics - (ATHE) Australia $0.037B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Aligos Therapeutics (ALGS) United States $0.036B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.036B 0.00
AN2 Therapeutics (ANTX) United States $0.036B 0.00
Boundless Bio (BOLD) United States $0.035B 0.00
Tenaya Therapeutics (TNYA) United States $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.033B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.033B 0.00
Bluebird Bio (BLUE) United States $0.032B 0.00
FibroBiologics (FBLG) United States $0.032B 0.00
Dyadic (DYAI) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.031B 0.00
Femasys (FEMY) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Radiopharm Theranostics - (RADX) Australia $0.030B 0.00
Scilex Holding (SCLX) United States $0.029B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
ABVC BioPharma (ABVC) United States $0.028B 0.00
Rani Therapeutics Holdings (RANI) United States $0.028B 0.00
CalciMedica (CALC) United States $0.027B 0.00
Grace Therapeutics (GRCE) Canada $0.026B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
ALX Oncology Holdings (ALXO) United States $0.026B 0.00
BioAtla (BCAB) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
OnKure Therapeutics (OKUR) United States $0.025B 0.00
Annovis Bio (ANVS) United States $0.024B 0.00
Clene (CLNN) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Quantum Biopharma (QNTM) Canada $0.023B 0.00
KALA BIO (KALA) United States $0.022B 0.00
Curis (CRIS) United States $0.022B 0.00
Advanced Biomed (ADVB) United States $0.022B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
Elevation Oncology (ELEV) United States $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.020B 0.00
Vor Biopharma (VOR) $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Lisata Therapeutics (LSTA) United States $0.020B 0.00
X4 Pharmaceuticals (XFOR) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.019B 0.00
Passage Bio (PASG) United States $0.018B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Leap Therapeutics (LPTX) United States $0.017B 0.00
HOOKIPA Pharma (HOOK) United States $0.017B 0.00
Kalaris Therapeutics (KLRS) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Moleculin Biotech (MBRX) United States $0.015B 0.00
IN8bio (INAB) United States $0.015B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
BioCardia (BCDA) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Gelteq (GELS) Australia $0.014B 0.00
Bolt Biotherapeutics (BOLT) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Synlogic (SYBX) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Rallybio (RLYB) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Hoth Therapeutics (HOTH) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
HCW Biologics (HCWB) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Athira Pharma (ATHA) United States $0.011B 0.00
LakeShore Biopharma (LSB) China $0.011B 0.00
Abpro Holdings (ABP) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.009B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Aytu BioPharma (AYTU) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
180 Life Sciences (ATNF) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
MetaVia (MTVA) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
BioAffinity Technologies (BIAF) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Eyenovia (EYEN) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Evaxion Biotech (EVAX) Denmark $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Affimed (AFMD) Germany $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Polyrizon (PLRZ) Israel $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00